Skip to main content

Table 2 Clinicopathological characteristics of GC according to presence of metachronous MPC

From: Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer

 

No MPC

Meta MPC

Pvalue

 

(n = 2996)

(n = 38)

 

Sex

   

  Male

2010 (67.1%)

32 (84.2%)

0.025

  Female

986 (32.9%)

6 (15.8%)

 

Age

57.2 ± 11.8

63.6 ± 7.7

<0.001

Stage

   

  I

1598 (53.3%)

26 (68.4%)

0.011

  II

430 (14.4%)

9 (23.7%)

 

  III

726 (24.2%)

3 (7.9%)

 

  IV

242 (8.1%)

0 (0%)

 

Multiplicity

   

  Single

2802 (93.5%)

29 (76.3%)

<0.001

  ≥2

194 (6.5%)

9 (23.7%)

 

Location

   

  Upper

1481 (50.4%)

19 (52.8%)

0.709

  Mid

1003 (34.1%)

10 (27.8%)

 

  Lower

339 (11.5%)

6 (16.7%)

 

  Diffuse

115 (3.9%)

1 (2.8%)

 

Cell type

   

  Tubular

2334 (77.9%)

32 (84.2%)

0.703

  Signet ring cell

503 (16.8%)

5 (13.2%)

 

  Mucinous

72 (2.4%)

0 (0%)

 

  Others

87 (2.9%)

1 (2.6%)

 

Maximal tumor size

4.1 ± 2.8

3.0 ± 1.8

<0.001

Initial CEA

4.6 ± 21.5

3.4 ± 4.1

0.763

Initial CA 19-9

40.1 ± 319.1

8.0 ± 6.9

0.662

Smoking History

   

  Current smoker

804 (27.2%)

14 (36.8%)

0.402

  Ex-smoker

406 (13.7%)

4 (10.5%)

 

  Never-smoker

1746 (59.1%)

20 (52.6%)

 

Alcoholic History

   

  Current drinker

1235 (41.8%)

22 (57.9%)

0.048

  Ex-drinker

196 (6.6%)

4 (10.5%)

 

  Never-drinker

1521 (51.5%)

12 (31.6%)

 

Outcome

   

  Alive

2290 (76.4%)

13 (34.2%)

 

  Dead

706 (23.6%)

25 (65.8%)